C07K 7/086
Bombesin
Official title: {Bombesin; Related peptides (having more than 20 amino acids C07K14/57572)}
C07K7/086 (Bombesin) appears on 53 US grants and 41 published applications in this corpus.
Search patents in C07K- Granted patents
- 53
- Published applications
- 41
- Assignees
- 44
- Inventors
- 147
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 7 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 1 |
| 2002 | 3 | 3 |
| 2003 | 1 | 5 |
| 2004 | 0 | 3 |
| 2005 | 2 | 3 |
| 2006 | 4 | 1 |
| 2007 | 2 | 4 |
| 2008 | 0 | 1 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 0 | 5 |
| 2012 | 0 | 0 |
| 2013 | 3 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 2 |
| 2016 | 1 | 0 |
| 2017 | 0 | 3 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- 18F-labeled peptide ligands useful in PET and Cerenkov luminescene imaging13 May 2025US 12,297,157 B2Cornell University
- Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same12 May 2020US 10,646,598 B2University of Southern California
- Suppression of prostate cancer using a targeted clostridial neurotoxin4 Feb 2020US 10,550,377 B2Ipsen Bioinnovation Limited
- Polypeptides that bind to and inhibit secretion from growth hormone secreting cells26 Mar 2019US 10,240,138 B2Ipsen Bioinnovation Limited
- Cage-like bifunctional chelators, copper-64 radiopharmaceuticals and PET imaging using the same2 Aug 2016US 9,403,875 B2University of Southern California
- 18f-labeled peptide ligands useful in pet and cerenkov luminescene imaging25 Dec 2025US 2025/0388523 A1Cornell University
- Radiopharmaceuticals, methods for the production thereof, and uses in treatment, diagnosis and imaging diseases21 Nov 2024US 2024/0382633 A1Clarity Pharmaceuticals Ltd
- Radiolabeled bombesin-derived compounds for in vivo imaging of gastrin-releasing peptide receptor (grpr) and treatment of grpr-related disorders30 Dec 2021US 2021/0402016 A1Provincial Health Services Authority
- 18f-labeled peptide ligands useful in pet and cerenkov luminescene imaging8 Oct 2020US 2020/0317588 A1Cornell University
- Kit for formulation of liposomal doxorubicin modified with bioactive peptides for selective targeting of receptors overexpressed by cancer cells27 Jul 2017US 2017/0209474 A1INVECTORS S.r.l.
Most cited
By later US patents
- Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity54US 5,833,985 AMedarex, Inc. · 1998
- Bombesin receptor antagonists and uses thereof44US 5,620,955 APeptide Technologies Corporation · 1997
- Therapeutic peptide derivatives32US 5,552,520 ABiomeasure, Inc. · 1996
- Linear therapeutic peptides28US 5,767,236 ABiomeasure, Inc. · 1998
- Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors27US 6,866,837 B2Mallinckrodt Inc. · 2005